Development of group 2 influenza a virus entry inhibitors
Ended Project Grant Awarded Last action
- Award ID
- R41AI145727
- Recipient
-
Chicago Biosolutions Inc. UEI KJL4YQ7KSEK9
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $599,998
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- Illinois, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $299,999 | |
| Original award | $299,999 |
Quick answers
Who received award R41AI145727?
R41AI145727 was awarded to Chicago Biosolutions Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 1, 2019.
How much is award R41AI145727 worth?
$599,998 has been obligated on R41AI145727.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award